BioSpace News Archive

BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, today announced that the company’s shareholders have decided to convert BioNTech’s corporate legal entity from the German “AG” (Aktiengesellschaft or share-based corporation) to a European company

January 4, 2019
·
4 min read
Business

Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target from Research Collaboration with Dicerna

Boehringer Ingelheim and Dicerna Pharmaceuticals announced that Boehringer Ingelheim has exercised an option to receive exclusive rights to a second hepatic disease target emerging from its research collaboration and license agreement with Dicerna.

January 4, 2019
·
7 min read
Deals

China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering

Shares to Commence Trading Today on the NASDAQ Capital Market as “SXTC”

January 4, 2019
·
5 min read
Business

Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary

Amneal Pharmaceuticals, Inc. announced that it has appointed David A. Buchen to the newly expanded role of Senior Vice President, Chief Legal Officer and Corporate Secretary, reporting to President and Chief Executive Officer Robert Stewart

January 4, 2019
·
7 min read
Business

C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-Based Medicines with Roche

C4 Therapeutics announced the transformation of its ongoing research and development partnership with Roche focusing on new cancer treatments based on C4T’s targeted protein degradation technology

January 4, 2019
·
1 min read
Drug Development

KalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans

KVD900 Phase 2 HAE Trial Data Expected in 2019

January 4, 2019
·
4 min read
Global Portable Oxygen Concentrators Market 2019-2023 | Increasing Number of Product Launches Impacting the Market Growth | Technavio

The global portable oxygen concentrators market 2019-2023 is expected to post a CAGR of close to 11% during the forecast period, according to the latest market research report by Technavio.

January 4, 2019
·
4 min read
Business

Civitas Senior Living Promotes Three More Executives

Elevation of Leadership Indicative of Rapid Growth, Progress

January 4, 2019
·
4 min read
ITC Savlon Celebrates World Braille Day

Introduces its first ever Braille enabled Pack in its portfolio

January 4, 2019
·
3 min read
Job Trends

Heska to Present at J.P. Morgan 2019 Healthcare Conference

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the J.P. Morgan 2019 Healthcare Conference on Thursday, January 10, 2019 at 11 a.m. PT in San Francisco, CA.

January 4, 2019
·
2 min read